The Products division focuses on providing a portfolio of specialist medicines to healthcare professionals and their patients in both licensed and unlicensed markets. This includes a range of niche and high-value products, such as those for oncology support, and treatments for various conditions like depressive disorder, type 2 diabetes mellitus, and respiratory disorders. Research and development activities within this segment involve identifying and acquiring promising therapies, securing regulatory approvals, and managing the supply chain to ensure product availability. The division leverages its expertise in global distribution and market access to reach patients with unmet needs. Future opportunities lie in expanding the product portfolio and geographic reach, with a focus on therapies that address critical medical needs. Regulatory compliance and clinical validation are key aspects of this segment, ensuring patient safety and efficacy.

The Services division provides a set of niche and high-value services to pharmaceutical and biotech clients prior to product launch. This includes clinical trial services, managed access programs, and commercialization support. The division's research and development activities are focused on developing innovative solutions for clinical trial supply and logistics, as well as providing support for early access programs. Technologies and methodologies used include advanced supply chain management, regulatory expertise, and global distribution networks. The therapeutic areas covered are broad, encompassing various disease areas where access to medicines is critical. The patient impact is significant, as the services facilitate access to potentially life-saving treatments. Market positioning is strong due to the company's expertise in navigating complex regulatory landscapes and providing global reach. Future opportunities include expanding service offerings and geographic presence, particularly in emerging markets. Partnerships and collaborations with pharmaceutical companies are crucial for the success of this segment.